Skip to content

ED-TREAT (Early Detection and Treatment to Reduce Events With Agitation Tool) Compared to Usual Care

A Pilot Randomized Controlled Trial of ED-TREAT (Early Detection and Treatment to Reduce Events With Agitation Tool) Compared to Usual Care

Status
Suspended
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04959279
Enrollment
26
Registered
2021-07-13
Start date
2026-04-01
Completion date
2026-08-01
Last updated
2026-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Behavioral Disorder, Psychomotor Agitation

Brief summary

The purpose of this study is to conduct a a pilot trial that tests the acceptability, fidelity, and feasibility of ED-TREAT.

Detailed description

This study will be a pilot RCT that compares ED-TREAT to usual care. The scientific premise of the proposed project is that an innovative EHR-embedded clinical decision support (CDS) tool can overcome the challenges to risk assessment and suggest pre-emptive use of behavioral techniques in the emergency setting. This would help clinicians appropriately invest resources to improve the quality of care for at-risk patients regardless of ultimate medical or psychiatric diagnoses and prevent agitation from occurring. This pilot trial will (1) test the integrity of the study protocol in preparation for a future full-scale RCT, (2) evaluate randomization protocols, (3) estimate rates of recruitment and retention, (4) assess acceptability and fidelity of the intervention, and (5) determine if the proposed effect size is reasonable. This registered study is actually the third aim of a larger study where the tool will be developed and assessed using observational data and input from a steering committee in aims 1 and 2 prior to pilot testing.

Interventions

OTHERED-TREAT

Patients will be assessed and treated based on a clinical decision support system.

Sponsors

Yale University
Lead SponsorOTHER
National Institute of Mental Health (NIMH)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Intervention model description

2:1 randomization and also recruit a higher proportion of high-risk patients in each arm

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. adult (age≥18) patients presenting to the YNHH ED during the pilot trial period 2. deemed to have a mild-moderate or high risk of agitation as determined by ED-TREAT 3. do not require physical restraint orders \<30 minutes of arrival 4. with a score of "4" (quiet and awake; normal level of activity) on the Behavioral Activity Rating Scale 5. have comfort with conversational English 6. able to provide verbal consent.

Exclusion criteria

1\. Presence of a restraint order \<30 minutes of arrival and presence of a non-violent physical restraint order where indications are not due to agitation (e.g., for protecting intubation or life-preserving equipment)

Design outcomes

Primary

MeasureTime frameDescription
Proportion of visits adherent to protocol12 monthsProportion of visits in the intervention arm that are adherent to \>95% of the observational workflow checklist (primary outcome of fidelity)

Secondary

MeasureTime frameDescription
System usability scaleBaseline, 15 hoursAcceptability will be measured using a scale the System Usability Scale. The System Usability Scale is a widely used and effective survey composed of ten statements assessed on a 5-point Likert scale, with inter-item correlations of 0.69-0.75 and a reliability coefficient α of 0.91. The scale provides continuous data from 0-100 with scores \>85 as indicative of excellent usability, and will be described using mean and standard deviation. The study will consider ED-TREAT to be acceptable if at least 90% of each clinician group give ratings \>85.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORAmbrose H. Wong, (203) 737-2489

Yale University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 13, 2026